Natural Biocon (India) Ltd (NATURAL) — shareholding pattern, promoter holding, financials and share price
About Natural Biocon (India) Ltd (NATURAL)
Natural Biocon (India) Ltd operates in the Pesticides & Agrochemicals industry, within the Chemicals sector. It trades on the NSE as NATURAL and on the BSE under scrip code 543207. Its ISIN is INE06MM01016.
Incorporated in 1992, Natural Biocon Ltd is engaged in the trading of agricultural produce. [1]
Natural Biocon (India) Ltd (NBL) is primarily engaged in the business of chemicals, natural extracts, and agricultural produce, focusing significantly on retail trading of these commodities.
The company has pioneered the use of natural color manufacturing, particularly utilizing Bixa orellana for food coloring, which is considered safer than synthetic options banned or restricted in several countries.
Listed peers in Pesticides & Agrochemicals: Nirman Agri Genetics Ltd, Adarsh Plant Protect Ltd, Continental Seeds and Chemicals Ltd, Phyto Chem (India) Ltd, Shanti Overseas (India) Ltd, PB Global Ltd.
Valuation & Returns
10 Jul 2026At ₹3.6 a share on 10 Jul 2026, Natural Biocon (India) Ltd (NATURAL) was valued at a price-to-earnings ratio of -310.33x against an industry P/E of 22.12x and a price-to-book of 0.29x on a book value of ₹12.36 per share as of Mar 2025. Solomo computes return on equity of -0.09% and return on capital employed of -0.09% from filed results. Earnings ratios use standalone results for the twelve months Jun 2025 to Mar 2026.
- P/E
- -310.33x
- Industry P/E
- 22.12x
- P/B
- 0.29x
- EPS (TTM)
- ₹-0.01
- Book value / share
- ₹12.36
- ROE
- -0.09%
- ROCE
- -0.09%
- ROA
- -0.08%
- Debt / equity
- 0.01x
- Dividend yield
- 0%
- EBITDA margin
- -1.18%
- 52-week range
- ₹3.04 – ₹13.51
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Natural Biocon (India) Ltd (NATURAL) reported revenue of ₹2.55 crore, net profit of ₹-0.04 crore and earnings per share of ₹-0.02. That compares with revenue of ₹8.35 crore and net profit of ₹0.04 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹0.88 crore and net profit ₹-0.09 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 0.48 | 1.25 | 13.53 | 8.35 | 2.55 |
| Net profit (₹ cr) | 0.07 | 0.18 | 0.15 | 0.04 | -0.04 |
| EPS (₹) | 0.06 | 0.16 | 0.13 | 0.02 | -0.02 |
| Measure | 10Y | 3Y | 1Y |
|---|---|---|---|
| Sales growth | 76.06% | 158.77% | -38.29% |
| Profit growth | - | -12.18% | -73.33% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 9.36% of Natural Biocon (India) Ltd (NATURAL) (unchanged from the previous quarter). Market capitalisation was ₹9 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2020.
Largest disclosed public shareholders in Jun 2026: AVENTEZ MEDIA & TECHNOLOGIES LIMITED 9.7%, AARNAH CAPITAL ADVISORS PVT LTD 9.7%, RICH POCKETS ONLINE SERVICES LIMITED 9.31%, NSCCL-WITHHOLD ACCOUNT 3.88%, JIGISH BHANUSHANKER TRIVEDI 3.41%, ARUNKUMAR DASHRATHBHAI PRAJAPATI HUF 3.37%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 9.36% | - | - | - | 90.64% |
| Mar 2026 | 9.36% | - | - | - | 90.64% |
| Dec 2025 | 9.36% | - | - | - | 90.64% |
| Sep 2025 | 9.36% | - | - | - | 90.64% |
| Jun 2025 | 9.36% | - | - | - | 90.64% |
| Mar 2025 | 9.36% | - | - | - | 90.64% |
| Dec 2024 | 9.36% | - | - | - | 90.64% |
| Sep 2024 | 9.36% | - | - | - | 90.64% |